INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2133568, encodeId=7739213356815, content=邀请了30多个审稿人没有同意审稿的该怎么办啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211118/2b3518894b7443769a3c33c6d1dfb17a/9438e388616e46dfa54e355d1ae1fe7d.jpg, createdBy=27495176994, createdName=146eb46fm56暂无昵称, createdTime=Sat May 13 17:52:30 CST 2023, time=2023-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978999, encodeId=41e89e8999e0, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：不到一个月修回，两个审稿人，只有第一个审稿人问了5个问题，都比较好回答，修回后20天接受，编辑也比较nice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Fri Jul 02 13:42:08 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953329, encodeId=a292953329ff, content=已经在编辑手上一个月了啊！有没有这种情况的大家讨论一下啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9cc05276494, createdName=14833954m75(暂无昵称), createdTime=Fri Apr 02 15:46:40 CST 2021, time=2021-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233631, encodeId=0ef31233631a9, content=请问爱思唯尔proof链接打不开怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e83e5631686, createdName=雨落殇殇, createdTime=Wed Jul 20 15:06:56 CST 2022, time=2022-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002430, encodeId=4538100243061, content=审稿速度:6.0 偏重的研究方向： chemotherapy ; 分子生物学 经验分享：请问这个杂志会接受纯生信的文章嘛，有人试过嘛?知道的可以回复一下嘛吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab581969258, createdName=wsasdeffgcf, createdTime=Sun Jul 25 02:56:01 CST 2021, time=2021-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094739, encodeId=7c1f2094e3960, content=请问收纯生信吗，有没有兄弟投过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6fa25623499, createdName=ms5000001211895712, createdTime=Wed Oct 19 15:32:51 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574158, encodeId=5ff55e415804, content=我看他家杂志投稿要求上写了是要求WB的结果要来自同一块胶，，是这样的嘛？Dr.Yang.YT 2019-04-20 00:00:00 发表: 不需要, beContent=Dr.Yang.YT 2019-04-20 00:00:00 发表: 不需要, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKQhT7IOpBia6qjHexOynRS6picWia9gvEgkh5zibRpeJheUfpxXV8cBKchEuwIWqmS3yUeQdcLU9EFlg/132, createdBy=f3fe5150334, createdName=是有想法的小星星, createdTime=Mon Jul 29 00:00:00 CST 2019, time=2019-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519584, encodeId=4c7d5195842e, content=with editor已经12天了，是什么情况啊？能写信催么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=391, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIradvotK0Q7ZZCxoBxn04UQ9sK4w7xoswia6qSeauYnNbhB9J8UHamWApEOIrXZ7Bwy9lJRmia00Qw/132, createdBy=c4da1646876, createdName=承诺, createdTime=Thu Feb 25 17:35:00 CST 2016, time=2016-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007084, encodeId=bae0100e084d1, content=请问各位大神及前辈这个杂志需要提供原始数据嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210526/24ec0c1bea544291bed1c3ec5108865c/27c2eec4e24f48a5ac78e8d4eda1b4ce.jpg, createdBy=7eda5316307, createdName=ran，, createdTime=Wed Aug 11 21:57:25 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221560, encodeId=a18e122156045, content=等了60天终于送审了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqySEUYKeYDjSbLFVeecL4pZwHOCeybI7fjfKQa8ib3KZudaDuuJ4HRI9zmVzRshXibZroeGiarzRy7Q/132, createdBy=30b05327262, createdName=Wsc990521, createdTime=Sun May 22 12:31:29 CST 2022, time=2022-05-22, status=1, ipAttribution=)]

2023-05-13 146eb46fm56暂无昵称

邀请了30多个审稿人没有同意审稿的该怎么办啊

0 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2133568, encodeId=7739213356815, content=邀请了30多个审稿人没有同意审稿的该怎么办啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211118/2b3518894b7443769a3c33c6d1dfb17a/9438e388616e46dfa54e355d1ae1fe7d.jpg, createdBy=27495176994, createdName=146eb46fm56暂无昵称, createdTime=Sat May 13 17:52:30 CST 2023, time=2023-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978999, encodeId=41e89e8999e0, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：不到一个月修回，两个审稿人，只有第一个审稿人问了5个问题，都比较好回答，修回后20天接受，编辑也比较nice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Fri Jul 02 13:42:08 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953329, encodeId=a292953329ff, content=已经在编辑手上一个月了啊！有没有这种情况的大家讨论一下啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9cc05276494, createdName=14833954m75(暂无昵称), createdTime=Fri Apr 02 15:46:40 CST 2021, time=2021-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233631, encodeId=0ef31233631a9, content=请问爱思唯尔proof链接打不开怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e83e5631686, createdName=雨落殇殇, createdTime=Wed Jul 20 15:06:56 CST 2022, time=2022-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002430, encodeId=4538100243061, content=审稿速度:6.0 偏重的研究方向： chemotherapy ; 分子生物学 经验分享：请问这个杂志会接受纯生信的文章嘛，有人试过嘛?知道的可以回复一下嘛吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab581969258, createdName=wsasdeffgcf, createdTime=Sun Jul 25 02:56:01 CST 2021, time=2021-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094739, encodeId=7c1f2094e3960, content=请问收纯生信吗，有没有兄弟投过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6fa25623499, createdName=ms5000001211895712, createdTime=Wed Oct 19 15:32:51 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574158, encodeId=5ff55e415804, content=我看他家杂志投稿要求上写了是要求WB的结果要来自同一块胶，，是这样的嘛？Dr.Yang.YT 2019-04-20 00:00:00 发表: 不需要, beContent=Dr.Yang.YT 2019-04-20 00:00:00 发表: 不需要, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKQhT7IOpBia6qjHexOynRS6picWia9gvEgkh5zibRpeJheUfpxXV8cBKchEuwIWqmS3yUeQdcLU9EFlg/132, createdBy=f3fe5150334, createdName=是有想法的小星星, createdTime=Mon Jul 29 00:00:00 CST 2019, time=2019-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519584, encodeId=4c7d5195842e, content=with editor已经12天了，是什么情况啊？能写信催么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=391, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIradvotK0Q7ZZCxoBxn04UQ9sK4w7xoswia6qSeauYnNbhB9J8UHamWApEOIrXZ7Bwy9lJRmia00Qw/132, createdBy=c4da1646876, createdName=承诺, createdTime=Thu Feb 25 17:35:00 CST 2016, time=2016-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007084, encodeId=bae0100e084d1, content=请问各位大神及前辈这个杂志需要提供原始数据嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210526/24ec0c1bea544291bed1c3ec5108865c/27c2eec4e24f48a5ac78e8d4eda1b4ce.jpg, createdBy=7eda5316307, createdName=ran，, createdTime=Wed Aug 11 21:57:25 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221560, encodeId=a18e122156045, content=等了60天终于送审了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqySEUYKeYDjSbLFVeecL4pZwHOCeybI7fjfKQa8ib3KZudaDuuJ4HRI9zmVzRshXibZroeGiarzRy7Q/132, createdBy=30b05327262, createdName=Wsc990521, createdTime=Sun May 22 12:31:29 CST 2022, time=2022-05-22, status=1, ipAttribution=)]

2021-07-02 小胖子罗军

审稿速度:1.0 | 投稿命中率:75.0
经验分享：不到一个月修回，两个审稿人，只有第一个审稿人问了5个问题，都比较好回答，修回后20天接受，编辑也比较nice

66 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2133568, encodeId=7739213356815, content=邀请了30多个审稿人没有同意审稿的该怎么办啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211118/2b3518894b7443769a3c33c6d1dfb17a/9438e388616e46dfa54e355d1ae1fe7d.jpg, createdBy=27495176994, createdName=146eb46fm56暂无昵称, createdTime=Sat May 13 17:52:30 CST 2023, time=2023-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978999, encodeId=41e89e8999e0, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：不到一个月修回，两个审稿人，只有第一个审稿人问了5个问题，都比较好回答，修回后20天接受，编辑也比较nice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Fri Jul 02 13:42:08 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953329, encodeId=a292953329ff, content=已经在编辑手上一个月了啊！有没有这种情况的大家讨论一下啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9cc05276494, createdName=14833954m75(暂无昵称), createdTime=Fri Apr 02 15:46:40 CST 2021, time=2021-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233631, encodeId=0ef31233631a9, content=请问爱思唯尔proof链接打不开怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e83e5631686, createdName=雨落殇殇, createdTime=Wed Jul 20 15:06:56 CST 2022, time=2022-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002430, encodeId=4538100243061, content=审稿速度:6.0 偏重的研究方向： chemotherapy ; 分子生物学 经验分享：请问这个杂志会接受纯生信的文章嘛，有人试过嘛?知道的可以回复一下嘛吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab581969258, createdName=wsasdeffgcf, createdTime=Sun Jul 25 02:56:01 CST 2021, time=2021-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094739, encodeId=7c1f2094e3960, content=请问收纯生信吗，有没有兄弟投过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6fa25623499, createdName=ms5000001211895712, createdTime=Wed Oct 19 15:32:51 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574158, encodeId=5ff55e415804, content=我看他家杂志投稿要求上写了是要求WB的结果要来自同一块胶，，是这样的嘛？Dr.Yang.YT 2019-04-20 00:00:00 发表: 不需要, beContent=Dr.Yang.YT 2019-04-20 00:00:00 发表: 不需要, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKQhT7IOpBia6qjHexOynRS6picWia9gvEgkh5zibRpeJheUfpxXV8cBKchEuwIWqmS3yUeQdcLU9EFlg/132, createdBy=f3fe5150334, createdName=是有想法的小星星, createdTime=Mon Jul 29 00:00:00 CST 2019, time=2019-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519584, encodeId=4c7d5195842e, content=with editor已经12天了，是什么情况啊？能写信催么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=391, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIradvotK0Q7ZZCxoBxn04UQ9sK4w7xoswia6qSeauYnNbhB9J8UHamWApEOIrXZ7Bwy9lJRmia00Qw/132, createdBy=c4da1646876, createdName=承诺, createdTime=Thu Feb 25 17:35:00 CST 2016, time=2016-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007084, encodeId=bae0100e084d1, content=请问各位大神及前辈这个杂志需要提供原始数据嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210526/24ec0c1bea544291bed1c3ec5108865c/27c2eec4e24f48a5ac78e8d4eda1b4ce.jpg, createdBy=7eda5316307, createdName=ran，, createdTime=Wed Aug 11 21:57:25 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221560, encodeId=a18e122156045, content=等了60天终于送审了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqySEUYKeYDjSbLFVeecL4pZwHOCeybI7fjfKQa8ib3KZudaDuuJ4HRI9zmVzRshXibZroeGiarzRy7Q/132, createdBy=30b05327262, createdName=Wsc990521, createdTime=Sun May 22 12:31:29 CST 2022, time=2022-05-22, status=1, ipAttribution=)]

2021-04-02 14833954m75(暂无昵称)

已经在编辑手上一个月了啊！有没有这种情况的大家讨论一下啊

102 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2133568, encodeId=7739213356815, content=邀请了30多个审稿人没有同意审稿的该怎么办啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211118/2b3518894b7443769a3c33c6d1dfb17a/9438e388616e46dfa54e355d1ae1fe7d.jpg, createdBy=27495176994, createdName=146eb46fm56暂无昵称, createdTime=Sat May 13 17:52:30 CST 2023, time=2023-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978999, encodeId=41e89e8999e0, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：不到一个月修回，两个审稿人，只有第一个审稿人问了5个问题，都比较好回答，修回后20天接受，编辑也比较nice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Fri Jul 02 13:42:08 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953329, encodeId=a292953329ff, content=已经在编辑手上一个月了啊！有没有这种情况的大家讨论一下啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9cc05276494, createdName=14833954m75(暂无昵称), createdTime=Fri Apr 02 15:46:40 CST 2021, time=2021-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233631, encodeId=0ef31233631a9, content=请问爱思唯尔proof链接打不开怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e83e5631686, createdName=雨落殇殇, createdTime=Wed Jul 20 15:06:56 CST 2022, time=2022-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002430, encodeId=4538100243061, content=审稿速度:6.0 偏重的研究方向： chemotherapy ; 分子生物学 经验分享：请问这个杂志会接受纯生信的文章嘛，有人试过嘛?知道的可以回复一下嘛吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab581969258, createdName=wsasdeffgcf, createdTime=Sun Jul 25 02:56:01 CST 2021, time=2021-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094739, encodeId=7c1f2094e3960, content=请问收纯生信吗，有没有兄弟投过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6fa25623499, createdName=ms5000001211895712, createdTime=Wed Oct 19 15:32:51 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574158, encodeId=5ff55e415804, content=我看他家杂志投稿要求上写了是要求WB的结果要来自同一块胶，，是这样的嘛？Dr.Yang.YT 2019-04-20 00:00:00 发表: 不需要, beContent=Dr.Yang.YT 2019-04-20 00:00:00 发表: 不需要, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKQhT7IOpBia6qjHexOynRS6picWia9gvEgkh5zibRpeJheUfpxXV8cBKchEuwIWqmS3yUeQdcLU9EFlg/132, createdBy=f3fe5150334, createdName=是有想法的小星星, createdTime=Mon Jul 29 00:00:00 CST 2019, time=2019-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519584, encodeId=4c7d5195842e, content=with editor已经12天了，是什么情况啊？能写信催么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=391, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIradvotK0Q7ZZCxoBxn04UQ9sK4w7xoswia6qSeauYnNbhB9J8UHamWApEOIrXZ7Bwy9lJRmia00Qw/132, createdBy=c4da1646876, createdName=承诺, createdTime=Thu Feb 25 17:35:00 CST 2016, time=2016-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007084, encodeId=bae0100e084d1, content=请问各位大神及前辈这个杂志需要提供原始数据嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210526/24ec0c1bea544291bed1c3ec5108865c/27c2eec4e24f48a5ac78e8d4eda1b4ce.jpg, createdBy=7eda5316307, createdName=ran，, createdTime=Wed Aug 11 21:57:25 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221560, encodeId=a18e122156045, content=等了60天终于送审了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqySEUYKeYDjSbLFVeecL4pZwHOCeybI7fjfKQa8ib3KZudaDuuJ4HRI9zmVzRshXibZroeGiarzRy7Q/132, createdBy=30b05327262, createdName=Wsc990521, createdTime=Sun May 22 12:31:29 CST 2022, time=2022-05-22, status=1, ipAttribution=)]

2022-07-20 雨落殇殇

请问爱思唯尔proof链接打不开怎么办

45 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2133568, encodeId=7739213356815, content=邀请了30多个审稿人没有同意审稿的该怎么办啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211118/2b3518894b7443769a3c33c6d1dfb17a/9438e388616e46dfa54e355d1ae1fe7d.jpg, createdBy=27495176994, createdName=146eb46fm56暂无昵称, createdTime=Sat May 13 17:52:30 CST 2023, time=2023-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978999, encodeId=41e89e8999e0, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：不到一个月修回，两个审稿人，只有第一个审稿人问了5个问题，都比较好回答，修回后20天接受，编辑也比较nice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Fri Jul 02 13:42:08 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953329, encodeId=a292953329ff, content=已经在编辑手上一个月了啊！有没有这种情况的大家讨论一下啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9cc05276494, createdName=14833954m75(暂无昵称), createdTime=Fri Apr 02 15:46:40 CST 2021, time=2021-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233631, encodeId=0ef31233631a9, content=请问爱思唯尔proof链接打不开怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e83e5631686, createdName=雨落殇殇, createdTime=Wed Jul 20 15:06:56 CST 2022, time=2022-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002430, encodeId=4538100243061, content=审稿速度:6.0 偏重的研究方向： chemotherapy ; 分子生物学 经验分享：请问这个杂志会接受纯生信的文章嘛，有人试过嘛?知道的可以回复一下嘛吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab581969258, createdName=wsasdeffgcf, createdTime=Sun Jul 25 02:56:01 CST 2021, time=2021-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094739, encodeId=7c1f2094e3960, content=请问收纯生信吗，有没有兄弟投过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6fa25623499, createdName=ms5000001211895712, createdTime=Wed Oct 19 15:32:51 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574158, encodeId=5ff55e415804, content=我看他家杂志投稿要求上写了是要求WB的结果要来自同一块胶，，是这样的嘛？Dr.Yang.YT 2019-04-20 00:00:00 发表: 不需要, beContent=Dr.Yang.YT 2019-04-20 00:00:00 发表: 不需要, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKQhT7IOpBia6qjHexOynRS6picWia9gvEgkh5zibRpeJheUfpxXV8cBKchEuwIWqmS3yUeQdcLU9EFlg/132, createdBy=f3fe5150334, createdName=是有想法的小星星, createdTime=Mon Jul 29 00:00:00 CST 2019, time=2019-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519584, encodeId=4c7d5195842e, content=with editor已经12天了，是什么情况啊？能写信催么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=391, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIradvotK0Q7ZZCxoBxn04UQ9sK4w7xoswia6qSeauYnNbhB9J8UHamWApEOIrXZ7Bwy9lJRmia00Qw/132, createdBy=c4da1646876, createdName=承诺, createdTime=Thu Feb 25 17:35:00 CST 2016, time=2016-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007084, encodeId=bae0100e084d1, content=请问各位大神及前辈这个杂志需要提供原始数据嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210526/24ec0c1bea544291bed1c3ec5108865c/27c2eec4e24f48a5ac78e8d4eda1b4ce.jpg, createdBy=7eda5316307, createdName=ran，, createdTime=Wed Aug 11 21:57:25 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221560, encodeId=a18e122156045, content=等了60天终于送审了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqySEUYKeYDjSbLFVeecL4pZwHOCeybI7fjfKQa8ib3KZudaDuuJ4HRI9zmVzRshXibZroeGiarzRy7Q/132, createdBy=30b05327262, createdName=Wsc990521, createdTime=Sun May 22 12:31:29 CST 2022, time=2022-05-22, status=1, ipAttribution=)]

2021-07-25 wsasdeffgcf

审稿速度:6.0
偏重的研究方向： chemotherapy ; 分子生物学
经验分享：请问这个杂志会接受纯生信的文章嘛，有人试过嘛?知道的可以回复一下嘛吗?

0 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2133568, encodeId=7739213356815, content=邀请了30多个审稿人没有同意审稿的该怎么办啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211118/2b3518894b7443769a3c33c6d1dfb17a/9438e388616e46dfa54e355d1ae1fe7d.jpg, createdBy=27495176994, createdName=146eb46fm56暂无昵称, createdTime=Sat May 13 17:52:30 CST 2023, time=2023-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978999, encodeId=41e89e8999e0, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：不到一个月修回，两个审稿人，只有第一个审稿人问了5个问题，都比较好回答，修回后20天接受，编辑也比较nice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Fri Jul 02 13:42:08 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953329, encodeId=a292953329ff, content=已经在编辑手上一个月了啊！有没有这种情况的大家讨论一下啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9cc05276494, createdName=14833954m75(暂无昵称), createdTime=Fri Apr 02 15:46:40 CST 2021, time=2021-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233631, encodeId=0ef31233631a9, content=请问爱思唯尔proof链接打不开怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e83e5631686, createdName=雨落殇殇, createdTime=Wed Jul 20 15:06:56 CST 2022, time=2022-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002430, encodeId=4538100243061, content=审稿速度:6.0 偏重的研究方向： chemotherapy ; 分子生物学 经验分享：请问这个杂志会接受纯生信的文章嘛，有人试过嘛?知道的可以回复一下嘛吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab581969258, createdName=wsasdeffgcf, createdTime=Sun Jul 25 02:56:01 CST 2021, time=2021-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094739, encodeId=7c1f2094e3960, content=请问收纯生信吗，有没有兄弟投过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6fa25623499, createdName=ms5000001211895712, createdTime=Wed Oct 19 15:32:51 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574158, encodeId=5ff55e415804, content=我看他家杂志投稿要求上写了是要求WB的结果要来自同一块胶，，是这样的嘛？Dr.Yang.YT 2019-04-20 00:00:00 发表: 不需要, beContent=Dr.Yang.YT 2019-04-20 00:00:00 发表: 不需要, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKQhT7IOpBia6qjHexOynRS6picWia9gvEgkh5zibRpeJheUfpxXV8cBKchEuwIWqmS3yUeQdcLU9EFlg/132, createdBy=f3fe5150334, createdName=是有想法的小星星, createdTime=Mon Jul 29 00:00:00 CST 2019, time=2019-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519584, encodeId=4c7d5195842e, content=with editor已经12天了，是什么情况啊？能写信催么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=391, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIradvotK0Q7ZZCxoBxn04UQ9sK4w7xoswia6qSeauYnNbhB9J8UHamWApEOIrXZ7Bwy9lJRmia00Qw/132, createdBy=c4da1646876, createdName=承诺, createdTime=Thu Feb 25 17:35:00 CST 2016, time=2016-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007084, encodeId=bae0100e084d1, content=请问各位大神及前辈这个杂志需要提供原始数据嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210526/24ec0c1bea544291bed1c3ec5108865c/27c2eec4e24f48a5ac78e8d4eda1b4ce.jpg, createdBy=7eda5316307, createdName=ran，, createdTime=Wed Aug 11 21:57:25 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221560, encodeId=a18e122156045, content=等了60天终于送审了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqySEUYKeYDjSbLFVeecL4pZwHOCeybI7fjfKQa8ib3KZudaDuuJ4HRI9zmVzRshXibZroeGiarzRy7Q/132, createdBy=30b05327262, createdName=Wsc990521, createdTime=Sun May 22 12:31:29 CST 2022, time=2022-05-22, status=1, ipAttribution=)]

2022-10-19 ms5000001211895712

请问收纯生信吗，有没有兄弟投过

43 0

[GetPortalCommentsPageByObjectIdResponse(id=2133568, encodeId=7739213356815, content=邀请了30多个审稿人没有同意审稿的该怎么办啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211118/2b3518894b7443769a3c33c6d1dfb17a/9438e388616e46dfa54e355d1ae1fe7d.jpg, createdBy=27495176994, createdName=146eb46fm56暂无昵称, createdTime=Sat May 13 17:52:30 CST 2023, time=2023-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978999, encodeId=41e89e8999e0, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：不到一个月修回，两个审稿人，只有第一个审稿人问了5个问题，都比较好回答，修回后20天接受，编辑也比较nice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Fri Jul 02 13:42:08 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953329, encodeId=a292953329ff, content=已经在编辑手上一个月了啊！有没有这种情况的大家讨论一下啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9cc05276494, createdName=14833954m75(暂无昵称), createdTime=Fri Apr 02 15:46:40 CST 2021, time=2021-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233631, encodeId=0ef31233631a9, content=请问爱思唯尔proof链接打不开怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e83e5631686, createdName=雨落殇殇, createdTime=Wed Jul 20 15:06:56 CST 2022, time=2022-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002430, encodeId=4538100243061, content=审稿速度:6.0 偏重的研究方向： chemotherapy ; 分子生物学 经验分享：请问这个杂志会接受纯生信的文章嘛，有人试过嘛?知道的可以回复一下嘛吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab581969258, createdName=wsasdeffgcf, createdTime=Sun Jul 25 02:56:01 CST 2021, time=2021-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094739, encodeId=7c1f2094e3960, content=请问收纯生信吗，有没有兄弟投过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6fa25623499, createdName=ms5000001211895712, createdTime=Wed Oct 19 15:32:51 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574158, encodeId=5ff55e415804, content=我看他家杂志投稿要求上写了是要求WB的结果要来自同一块胶，，是这样的嘛？Dr.Yang.YT 2019-04-20 00:00:00 发表: 不需要, beContent=Dr.Yang.YT 2019-04-20 00:00:00 发表: 不需要, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKQhT7IOpBia6qjHexOynRS6picWia9gvEgkh5zibRpeJheUfpxXV8cBKchEuwIWqmS3yUeQdcLU9EFlg/132, createdBy=f3fe5150334, createdName=是有想法的小星星, createdTime=Mon Jul 29 00:00:00 CST 2019, time=2019-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519584, encodeId=4c7d5195842e, content=with editor已经12天了，是什么情况啊？能写信催么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=391, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIradvotK0Q7ZZCxoBxn04UQ9sK4w7xoswia6qSeauYnNbhB9J8UHamWApEOIrXZ7Bwy9lJRmia00Qw/132, createdBy=c4da1646876, createdName=承诺, createdTime=Thu Feb 25 17:35:00 CST 2016, time=2016-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007084, encodeId=bae0100e084d1, content=请问各位大神及前辈这个杂志需要提供原始数据嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210526/24ec0c1bea544291bed1c3ec5108865c/27c2eec4e24f48a5ac78e8d4eda1b4ce.jpg, createdBy=7eda5316307, createdName=ran，, createdTime=Wed Aug 11 21:57:25 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221560, encodeId=a18e122156045, content=等了60天终于送审了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqySEUYKeYDjSbLFVeecL4pZwHOCeybI7fjfKQa8ib3KZudaDuuJ4HRI9zmVzRshXibZroeGiarzRy7Q/132, createdBy=30b05327262, createdName=Wsc990521, createdTime=Sun May 22 12:31:29 CST 2022, time=2022-05-22, status=1, ipAttribution=)]

2019-07-29 是有想法的小星星

我看他家杂志投稿要求上写了是要求WB的结果要来自同一块胶，，是这样的嘛？Dr.Yang.YT 2019-04-20 00:00:00 发表:
不需要

Dr.Yang.YT 2019-04-20 00:00:00 发表: 不需要

135 0

[GetPortalCommentsPageByObjectIdResponse(id=2133568, encodeId=7739213356815, content=邀请了30多个审稿人没有同意审稿的该怎么办啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211118/2b3518894b7443769a3c33c6d1dfb17a/9438e388616e46dfa54e355d1ae1fe7d.jpg, createdBy=27495176994, createdName=146eb46fm56暂无昵称, createdTime=Sat May 13 17:52:30 CST 2023, time=2023-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978999, encodeId=41e89e8999e0, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：不到一个月修回，两个审稿人，只有第一个审稿人问了5个问题，都比较好回答，修回后20天接受，编辑也比较nice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Fri Jul 02 13:42:08 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953329, encodeId=a292953329ff, content=已经在编辑手上一个月了啊！有没有这种情况的大家讨论一下啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9cc05276494, createdName=14833954m75(暂无昵称), createdTime=Fri Apr 02 15:46:40 CST 2021, time=2021-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233631, encodeId=0ef31233631a9, content=请问爱思唯尔proof链接打不开怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e83e5631686, createdName=雨落殇殇, createdTime=Wed Jul 20 15:06:56 CST 2022, time=2022-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002430, encodeId=4538100243061, content=审稿速度:6.0 偏重的研究方向： chemotherapy ; 分子生物学 经验分享：请问这个杂志会接受纯生信的文章嘛，有人试过嘛?知道的可以回复一下嘛吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab581969258, createdName=wsasdeffgcf, createdTime=Sun Jul 25 02:56:01 CST 2021, time=2021-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094739, encodeId=7c1f2094e3960, content=请问收纯生信吗，有没有兄弟投过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6fa25623499, createdName=ms5000001211895712, createdTime=Wed Oct 19 15:32:51 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574158, encodeId=5ff55e415804, content=我看他家杂志投稿要求上写了是要求WB的结果要来自同一块胶，，是这样的嘛？Dr.Yang.YT 2019-04-20 00:00:00 发表: 不需要, beContent=Dr.Yang.YT 2019-04-20 00:00:00 发表: 不需要, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKQhT7IOpBia6qjHexOynRS6picWia9gvEgkh5zibRpeJheUfpxXV8cBKchEuwIWqmS3yUeQdcLU9EFlg/132, createdBy=f3fe5150334, createdName=是有想法的小星星, createdTime=Mon Jul 29 00:00:00 CST 2019, time=2019-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519584, encodeId=4c7d5195842e, content=with editor已经12天了，是什么情况啊？能写信催么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=391, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIradvotK0Q7ZZCxoBxn04UQ9sK4w7xoswia6qSeauYnNbhB9J8UHamWApEOIrXZ7Bwy9lJRmia00Qw/132, createdBy=c4da1646876, createdName=承诺, createdTime=Thu Feb 25 17:35:00 CST 2016, time=2016-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007084, encodeId=bae0100e084d1, content=请问各位大神及前辈这个杂志需要提供原始数据嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210526/24ec0c1bea544291bed1c3ec5108865c/27c2eec4e24f48a5ac78e8d4eda1b4ce.jpg, createdBy=7eda5316307, createdName=ran，, createdTime=Wed Aug 11 21:57:25 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221560, encodeId=a18e122156045, content=等了60天终于送审了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqySEUYKeYDjSbLFVeecL4pZwHOCeybI7fjfKQa8ib3KZudaDuuJ4HRI9zmVzRshXibZroeGiarzRy7Q/132, createdBy=30b05327262, createdName=Wsc990521, createdTime=Sun May 22 12:31:29 CST 2022, time=2022-05-22, status=1, ipAttribution=)]

2016-02-25 承诺

with editor已经12天了，是什么情况啊？能写信催么?

391 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2133568, encodeId=7739213356815, content=邀请了30多个审稿人没有同意审稿的该怎么办啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211118/2b3518894b7443769a3c33c6d1dfb17a/9438e388616e46dfa54e355d1ae1fe7d.jpg, createdBy=27495176994, createdName=146eb46fm56暂无昵称, createdTime=Sat May 13 17:52:30 CST 2023, time=2023-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978999, encodeId=41e89e8999e0, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：不到一个月修回，两个审稿人，只有第一个审稿人问了5个问题，都比较好回答，修回后20天接受，编辑也比较nice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Fri Jul 02 13:42:08 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953329, encodeId=a292953329ff, content=已经在编辑手上一个月了啊！有没有这种情况的大家讨论一下啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9cc05276494, createdName=14833954m75(暂无昵称), createdTime=Fri Apr 02 15:46:40 CST 2021, time=2021-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233631, encodeId=0ef31233631a9, content=请问爱思唯尔proof链接打不开怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e83e5631686, createdName=雨落殇殇, createdTime=Wed Jul 20 15:06:56 CST 2022, time=2022-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002430, encodeId=4538100243061, content=审稿速度:6.0 偏重的研究方向： chemotherapy ; 分子生物学 经验分享：请问这个杂志会接受纯生信的文章嘛，有人试过嘛?知道的可以回复一下嘛吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab581969258, createdName=wsasdeffgcf, createdTime=Sun Jul 25 02:56:01 CST 2021, time=2021-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094739, encodeId=7c1f2094e3960, content=请问收纯生信吗，有没有兄弟投过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6fa25623499, createdName=ms5000001211895712, createdTime=Wed Oct 19 15:32:51 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574158, encodeId=5ff55e415804, content=我看他家杂志投稿要求上写了是要求WB的结果要来自同一块胶，，是这样的嘛？Dr.Yang.YT 2019-04-20 00:00:00 发表: 不需要, beContent=Dr.Yang.YT 2019-04-20 00:00:00 发表: 不需要, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKQhT7IOpBia6qjHexOynRS6picWia9gvEgkh5zibRpeJheUfpxXV8cBKchEuwIWqmS3yUeQdcLU9EFlg/132, createdBy=f3fe5150334, createdName=是有想法的小星星, createdTime=Mon Jul 29 00:00:00 CST 2019, time=2019-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519584, encodeId=4c7d5195842e, content=with editor已经12天了，是什么情况啊？能写信催么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=391, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIradvotK0Q7ZZCxoBxn04UQ9sK4w7xoswia6qSeauYnNbhB9J8UHamWApEOIrXZ7Bwy9lJRmia00Qw/132, createdBy=c4da1646876, createdName=承诺, createdTime=Thu Feb 25 17:35:00 CST 2016, time=2016-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007084, encodeId=bae0100e084d1, content=请问各位大神及前辈这个杂志需要提供原始数据嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210526/24ec0c1bea544291bed1c3ec5108865c/27c2eec4e24f48a5ac78e8d4eda1b4ce.jpg, createdBy=7eda5316307, createdName=ran，, createdTime=Wed Aug 11 21:57:25 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221560, encodeId=a18e122156045, content=等了60天终于送审了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqySEUYKeYDjSbLFVeecL4pZwHOCeybI7fjfKQa8ib3KZudaDuuJ4HRI9zmVzRshXibZroeGiarzRy7Q/132, createdBy=30b05327262, createdName=Wsc990521, createdTime=Sun May 22 12:31:29 CST 2022, time=2022-05-22, status=1, ipAttribution=)]

2021-08-11 ran，

请问各位大神及前辈这个杂志需要提供原始数据嘛

80 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2133568, encodeId=7739213356815, content=邀请了30多个审稿人没有同意审稿的该怎么办啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211118/2b3518894b7443769a3c33c6d1dfb17a/9438e388616e46dfa54e355d1ae1fe7d.jpg, createdBy=27495176994, createdName=146eb46fm56暂无昵称, createdTime=Sat May 13 17:52:30 CST 2023, time=2023-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978999, encodeId=41e89e8999e0, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：不到一个月修回，两个审稿人，只有第一个审稿人问了5个问题，都比较好回答，修回后20天接受，编辑也比较nice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Fri Jul 02 13:42:08 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953329, encodeId=a292953329ff, content=已经在编辑手上一个月了啊！有没有这种情况的大家讨论一下啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9cc05276494, createdName=14833954m75(暂无昵称), createdTime=Fri Apr 02 15:46:40 CST 2021, time=2021-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233631, encodeId=0ef31233631a9, content=请问爱思唯尔proof链接打不开怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e83e5631686, createdName=雨落殇殇, createdTime=Wed Jul 20 15:06:56 CST 2022, time=2022-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002430, encodeId=4538100243061, content=审稿速度:6.0 偏重的研究方向： chemotherapy ; 分子生物学 经验分享：请问这个杂志会接受纯生信的文章嘛，有人试过嘛?知道的可以回复一下嘛吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab581969258, createdName=wsasdeffgcf, createdTime=Sun Jul 25 02:56:01 CST 2021, time=2021-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094739, encodeId=7c1f2094e3960, content=请问收纯生信吗，有没有兄弟投过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6fa25623499, createdName=ms5000001211895712, createdTime=Wed Oct 19 15:32:51 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574158, encodeId=5ff55e415804, content=我看他家杂志投稿要求上写了是要求WB的结果要来自同一块胶，，是这样的嘛？Dr.Yang.YT 2019-04-20 00:00:00 发表: 不需要, beContent=Dr.Yang.YT 2019-04-20 00:00:00 发表: 不需要, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKQhT7IOpBia6qjHexOynRS6picWia9gvEgkh5zibRpeJheUfpxXV8cBKchEuwIWqmS3yUeQdcLU9EFlg/132, createdBy=f3fe5150334, createdName=是有想法的小星星, createdTime=Mon Jul 29 00:00:00 CST 2019, time=2019-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519584, encodeId=4c7d5195842e, content=with editor已经12天了，是什么情况啊？能写信催么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=391, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIradvotK0Q7ZZCxoBxn04UQ9sK4w7xoswia6qSeauYnNbhB9J8UHamWApEOIrXZ7Bwy9lJRmia00Qw/132, createdBy=c4da1646876, createdName=承诺, createdTime=Thu Feb 25 17:35:00 CST 2016, time=2016-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007084, encodeId=bae0100e084d1, content=请问各位大神及前辈这个杂志需要提供原始数据嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210526/24ec0c1bea544291bed1c3ec5108865c/27c2eec4e24f48a5ac78e8d4eda1b4ce.jpg, createdBy=7eda5316307, createdName=ran，, createdTime=Wed Aug 11 21:57:25 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221560, encodeId=a18e122156045, content=等了60天终于送审了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqySEUYKeYDjSbLFVeecL4pZwHOCeybI7fjfKQa8ib3KZudaDuuJ4HRI9zmVzRshXibZroeGiarzRy7Q/132, createdBy=30b05327262, createdName=Wsc990521, createdTime=Sun May 22 12:31:29 CST 2022, time=2022-05-22, status=1, ipAttribution=)]

2022-05-22 Wsc990521

等了60天终于送审了……

56 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务